Michael B. Hoffman - 07 Apr 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: ANVS
Reported as of: 07 Apr 2023
Net transaction value: +$750,005
SEC form: 4
Accepted by SEC: 11 Apr 2023, 21:06:18 UTC
Prior SEC filing: 20 Jan 2023
Next SEC filing: 03 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Henry Hagopian III, Attorney-in-Fact for Michael Hoffman

Key filing fact

Michael B. Hoffman filed Form 4 for Annovis Bio, Inc. (ANVS) on 11 Apr 2023.

Key facts

This page summarizes Michael B. Hoffman's Form 4 filing for Annovis Bio, Inc. (ANVS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Apr 2023, 21:06.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

ANVS transaction

Award

ANVS holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.